2019-20流感季美国孕妇流感与Tdap疫苗接种覆盖率
CDC分析2020年4月互联网调查数据,评估2019-20流感季孕妇流感疫苗和Tdap接种覆盖率。1841名受访者中61.2%接种流感疫苗,较2018-19季上升7.5个百分点;463名活产者中56.6%接种Tdap,与上季相似。提供接种建议或转诊的孕妇覆盖率最高,种族差异持续存在。
要点
- 2019-20季孕妇流感疫苗接种率61.2%,较上季上升7.5个百分点。
- 活产者中Tdap接种率56.6%,与2018-19季相似。
- 提供者建议或转诊可提高接种率,但种族差异仍存在。
核心结论
- 孕妇流感疫苗接种覆盖率较上季上升,但Tdap接种率未变,两者均未达最优且种族差异持续。
研究设计与样本
- CDC于2020年4月开展的互联网面板调查,分析2019-20流感季孕妇数据。
主要发现
- 1841名受访者中61.2%报告在孕前或孕期接种流感疫苗,较2018-19季上升7.5个百分点。
- 463名活产受访者中56.6%报告孕期接种Tdap,与2018-19季相似。
- 报告收到提供者接种建议或转诊者覆盖率最高:流感75.2%,Tdap72.7%。
- 非西班牙裔黑人女性流感接种率上升14.7个百分点至52.7%,西班牙裔上升9.9个百分点至67.2%,其他非西班牙裔种族上升7.9个百分点至69.6%,非西班牙裔白人保持60.6%。
- 西班牙裔和黑人女性Tdap接种率最低(分别为35.8%和38.8%),白人女性65.5%,其他种族54.0%;西班牙裔女性Tdap接种率较上季下降。
关键数值与推荐
- ACIP建议所有在流感季节怀孕或可能怀孕的女性接种流感疫苗,孕期任何时间均可接种。
- ACIP建议每次妊娠均接种Tdap,最好在孕27-36周早期接种。
临床怎么用
- 临床应持续向孕妇提供流感疫苗和Tdap接种建议或转诊,以提高覆盖率。
- 针对不同种族/族裔患者,采用文化和语言上量身定制的沟通方式,以减少接种差异。
局限性
- 原文未报告调查方法学局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccination of pregnant women with influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) can decrease the risk for influenza and pertussis among pregnant women and their infants. The Advisory Committee on Immunization Practices (ACIP) recommends that all women who are or might be pregnant during the influenza season receive influenza vaccine, which can be administered at any time during pregnancy (1). ACIP also recommends that women receive Tdap during each pregnancy, preferably during the early part of gestational weeks 27-36 (2,3). Despite these recommendations, vaccination coverage among pregnant women has been found to be suboptimal with racial/ethnic disparities persisting (4-6). To assess influenza and Tdap vaccination coverage among women pregnant during the 2019-20 influenza season, CDC analyzed data from an Internet panel survey conducted during April 2020. Among 1,841 survey respondents who were pregnant anytime during October 2019-January 2020, 61.2% reported receiving influenza vaccine before or during their pregnancy, an increase of 7.5 percentage points compared with the rate during the 2018-19 season. Among 463 respondents who had a live birth by their survey date, 56.6% reported receiving Tdap during pregnancy, similar to the 2018-19 season (4). Vaccination coverage was highest among women who reported receiving a provider offer or referral for vaccination (influenza = 75.2%; Tdap = 72.7%). Compared with the 2018-19 season, increases in influenza vaccination coverage were observed during the 2019-20 season for non-Hispanic Black (Black) women (14.7 percentage points, to 52.7%), Hispanic women (9.9 percentage points, to 67.2%), and women of other non-Hispanic (other) races (7.9 percentage points, to 69.6%), and did not change for non-Hispanic White (White) women (60.6%). As in the 2018-19 season, Hispanic and Black women had the lowest Tdap vaccination coverage (35.8% and 38.8%, respectively), compared with White women (65.5%) and women of other races (54.0%); in addition, a decrease in Tdap vaccination coverage was observed among Hispanic women in 2019-20 compared with the previous season. Racial/ethnic disparities in influenza vaccination coverage decreased but persisted, even among women who received a provider offer or referral for vaccination. Consistent provider offers or referrals, in combination with conversations culturally and linguistically tailored for patients of all races/ethnicities, could increase vaccination coverage among pregnant women in all racial/ethnic groups and reduce disparities in coverage.
引用
- Razzaghi H, Kahn KE, Black CL, et al. Influenza and Tdap Vaccination Coverage Among Pregnant Women - United States, April 2020. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33001873. doi:10.15585/mmwr.mm6939a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。